Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamiparib in Advanced Ovarian Cancer and TNBC (China Phase I/II)
CTR20160828Phase 2Completed
- Sponsor
- BeiGene
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pamiparib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), triple-negative breast cancer (TNBC), sponsored by BeiGene. Started Dec 2016; status: completed.
02
Drugs
pamiparib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on CTR20160828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160828.